{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04569435",
            "orgStudyIdInfo": {
                "id": "ANX005-ALS-01"
            },
            "organization": {
                "fullName": "Annexon, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)",
            "officialTitle": "A Phase 2a Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Study of Intravenous ANX005 in Subjects With Amyotrophic Lateral Sclerosis (ALS)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-of-in-adults-with-amyotrophic-lateral-sclerosis-als"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-01-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-09-23",
            "studyFirstSubmitQcDate": "2020-09-24",
            "studyFirstPostDateStruct": {
                "date": "2020-09-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-03-23",
            "lastUpdatePostDateStruct": {
                "date": "2023-03-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Annexon, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is a multi-center, open-label study of intravenous (IV) ANX005 in participants with ALS.",
            "detailedDescription": "In this Phase 2a, multi-center, open label, proof-of-biology study, ANX005 will be administered to participants with ALS.\n\nThe study consists of approximately 22 weeks of treatment and approximately 14 weeks of follow-up. All participants will be contacted by phone 6 months after study completion."
        },
        "conditionsModule": {
            "conditions": [
                "Amyotrophic Lateral Sclerosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "ANX005",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive induction dosing of ANX005 on Days 1 and 5 or 6, followed by maintenance doses of ANX005 every 2 weeks up to Week 22.",
                    "interventionNames": [
                        "Drug: ANX005"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "ANX005",
                    "description": "IV Infusion",
                    "armGroupLabels": [
                        "ANX005"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants Who Experienced Treatment-Emergent Adverse Events",
                    "timeFrame": "Up to Week 36"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Serum Concentrations of ANX005",
                    "timeFrame": "Up to Week 36"
                },
                {
                    "measure": "Maximum Observed Serum Concentration (Cmax) of ANX005",
                    "timeFrame": "Day 1 and Week 24"
                },
                {
                    "measure": "Area Under the ANX005 Serum Concentration-Time Curve",
                    "timeFrame": "Day 1 and Week 24"
                },
                {
                    "measure": "Change from Baseline in Free Complement (C) 1q Serum Concentrations",
                    "timeFrame": "Baseline, up to Week 36"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Diagnosis of ALS according to the World Federation of Neurology revised EI Escorial criteria.\n* Onset of weakness within 3 years prior to Day 1 visit.\n* Slow Vital Capacity \u2265 50% of predicted normal adjusted for sex, age, and height (from the sitting position).\n* ALS Functional Rating Scale-Revised (ALSFRS-R) \u2265 30 at the Screening visit (Week -2).\n* If female, must be postmenopausal, surgically sterilized, or agree to use highly effective methods of contraception from Screening through Week 36.\n* Males with a woman partner of childbearing potential must agree to use highly effective methods of contraception from Screening through Week 36.\n* Documented history of vaccinations within 5 years prior to Screening visit against encapsulated bacterial pathogens or willing to undergo vaccinations.\n\nKey Exclusion Criteria:\n\n* Clinically significant, ongoing or intercurrent illness, medical condition, or medical history that would jeopardize the safety of the participant, limit participation, or compromise the interpretation of the safety data derived from the participant.\n* Participants with body weight \\> 150 kilograms.\n* Antinuclear antibodies (ANA) titer \u2265 1:160 (for either of the 2 ANA results a minimum of 2 weeks apart) during the Screening Period.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Study Coordinator",
                    "role": "CONTACT",
                    "phone": "650-822-5500",
                    "email": "clinicaltrials@annexonbio.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Benjamin Hoehn, MD, PhD",
                    "affiliation": "Annexon, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Annexon Investigational Site 04",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85013",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "650-822-5500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Annexon Investigational Site 01",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "California",
                    "zip": "9492868",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "650-822-5500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "Annexon Investigational Site 05",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "650-822-5500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Annexon Investigational Site 02",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32608",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "650-822-5500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                },
                {
                    "facility": "Annexon Investigational Site 03",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "650-822-5500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Annexon Investigational Site 06",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "650-822-5500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Annexon Investigational Site 10",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 2R7",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "6508225500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "Annexon Investigational Site 11",
                    "status": "RECRUITING",
                    "city": "Fredericton",
                    "state": "New Brunswick",
                    "zip": "N8 E3B 0C7",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "6508225500",
                            "email": "Clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.94541,
                        "lon": -66.66558
                    }
                },
                {
                    "facility": "Annexon Investigational Site 09",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M4N 3M5",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "6508225500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Annexon Investigational Site 07",
                    "status": "RECRUITING",
                    "city": "Montr\u00e9al",
                    "state": "Quebec",
                    "zip": "H2X 0A9",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "6508225500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Annexon Investigational Site 08",
                    "status": "RECRUITING",
                    "city": "Montr\u00e9al",
                    "state": "Quebec",
                    "zip": "H3A 2B4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "6508225500",
                            "email": "clinicaltrials@annexonbio.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "France"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016472",
                    "term": "Motor Neuron Disease"
                },
                {
                    "id": "D000000690",
                    "term": "Amyotrophic Lateral Sclerosis"
                },
                {
                    "id": "D000012598",
                    "term": "Sclerosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000013118",
                    "term": "Spinal Cord Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000057177",
                    "term": "TDP-43 Proteinopathies"
                },
                {
                    "id": "D000057165",
                    "term": "Proteostasis Deficiencies"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M18879",
                    "name": "Motor Neuron Disease",
                    "asFound": "Lateral Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4024",
                    "name": "Amyotrophic Lateral Sclerosis",
                    "asFound": "Amyotrophic Lateral Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15415",
                    "name": "Sclerosis",
                    "asFound": "Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15915",
                    "name": "Spinal Cord Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28759",
                    "name": "TDP-43 Proteinopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M28747",
                    "name": "Proteostasis Deficiencies",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T349",
                    "name": "Amyotrophic Lateral Sclerosis",
                    "asFound": "Amyotrophic Lateral Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4699",
                    "name": "Primary Lateral Sclerosis",
                    "asFound": "Lateral Sclerosis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}